Jared Linthicum

410 total citations
11 papers, 245 citations indexed

About

Jared Linthicum is a scholar working on Psychiatry and Mental health, Pharmacology and Social Psychology. According to data from OpenAlex, Jared Linthicum has authored 11 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 3 papers in Social Psychology. Recurrent topics in Jared Linthicum's work include Schizophrenia research and treatment (4 papers), Neuroendocrine regulation and behavior (3 papers) and Cannabis and Cannabinoid Research (3 papers). Jared Linthicum is often cited by papers focused on Schizophrenia research and treatment (4 papers), Neuroendocrine regulation and behavior (3 papers) and Cannabis and Cannabinoid Research (3 papers). Jared Linthicum collaborates with scholars based in United States and South Korea. Jared Linthicum's co-authors include Robert P. McMahon, Deanna L. Kelly, Robert W. Buchanan, Heidi J. Wehring, Douglas L. Boggs, Gregory P. Strauss, David A. Gorelick, Mary R. Lee, Fang Liu and Alan S. Bellack and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychiatry Research and Schizophrenia Research.

In The Last Decade

Jared Linthicum

11 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jared Linthicum United States 8 90 72 62 52 41 11 245
Nikita Jegan Germany 8 129 1.4× 130 1.8× 87 1.4× 20 0.4× 44 1.1× 11 336
Tatu Kantonen Finland 7 26 0.3× 44 0.6× 26 0.4× 62 1.2× 7 0.2× 11 227
Kimberly R. Warren United States 7 32 0.4× 69 1.0× 210 3.4× 51 1.0× 6 0.1× 11 429
Sean M. Mooney‐Leber United States 9 85 0.9× 12 0.2× 9 0.1× 37 0.7× 26 0.6× 16 283
Siobhan Morse United States 9 43 0.5× 58 0.8× 91 1.5× 122 2.3× 2 0.0× 18 308
Timothy Whitaker United States 6 21 0.2× 102 1.4× 188 3.0× 53 1.0× 14 0.3× 14 580
Chiara Mattei Italy 11 14 0.2× 39 0.5× 119 1.9× 16 0.3× 9 0.2× 12 285
Agnese Marsano Italy 7 29 0.3× 82 1.1× 66 1.1× 33 0.6× 3 0.1× 10 294
S. Rasmussen Denmark 6 28 0.3× 93 1.3× 110 1.8× 66 1.3× 13 0.3× 11 434
Elisabeth Paul Sweden 7 31 0.3× 36 0.5× 26 0.4× 63 1.2× 2 0.0× 12 244

Countries citing papers authored by Jared Linthicum

Since Specialization
Citations

This map shows the geographic impact of Jared Linthicum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared Linthicum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared Linthicum more than expected).

Fields of papers citing papers by Jared Linthicum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared Linthicum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared Linthicum. The network helps show where Jared Linthicum may publish in the future.

Co-authorship network of co-authors of Jared Linthicum

This figure shows the co-authorship network connecting the top 25 collaborators of Jared Linthicum. A scholar is included among the top collaborators of Jared Linthicum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared Linthicum. Jared Linthicum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Horan, William P., Colin A. Depp, Samantha Hurst, et al.. (2023). Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia: A Multi-Stakeholder Perspective. Schizophrenia Bulletin Open. 4(1). sgad012–sgad012. 2 indexed citations
2.
Lee, Mary R., Heidi J. Wehring, Robert P. McMahon, et al.. (2019). The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report. SHILAP Revista de lepidopterología. 4(1). 11 indexed citations
3.
Lee, Mary R., Heidi J. Wehring, Robert P. McMahon, et al.. (2016). Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia. Schizophrenia Research. 172(1-3). 165–168. 19 indexed citations
4.
Brodey, Benjamin B., et al.. (2015). Validation of the NetSCID: an automated web-based adaptive version of the SCID. Comprehensive Psychiatry. 66. 67–70. 29 indexed citations
5.
Lee, Mary R., Heidi J. Wehring, Robert P. McMahon, et al.. (2013). Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study. Schizophrenia Research. 145(1-3). 110–115. 62 indexed citations
6.
Koola, Maju Mathew, Douglas L. Boggs, Deanna L. Kelly, et al.. (2013). Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry Research. 209(3). 273–278. 7 indexed citations
7.
Boggs, Douglas L., Deanna L. Kelly, Fang Liu, et al.. (2012). Cannabis withdrawal in chronic cannabis users with schizophrenia. Journal of Psychiatric Research. 47(2). 240–245. 13 indexed citations
8.
Wehring, Heidi J., Mary R. Lee, Robert P. McMahon, et al.. (2012). Poster #220 INTRANASAL OXYTOCIN EFFECTS ON SOCIAL ANXIETY AND DEPRESSION IN SCHIZOPHRENIA: RESULTS FROM A DOUBLE BLIND PLACEBO CONTROLLED TRIAL. Schizophrenia Research. 136. S360–S360. 2 indexed citations
9.
Boggs, Douglas L., Deanna L. Kelly, Robert P. McMahon, et al.. (2011). Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial. Schizophrenia Research. 134(2-3). 207–210. 34 indexed citations
10.
Kelly, Deanna L., David A. Gorelick, Robert R. Conley, et al.. (2010). Effects of the Cannabinoid-1 Receptor Antagonist Rimonabant on Psychiatric Symptoms in Overweight People With Schizophrenia. Journal of Clinical Psychopharmacology. 31(1). 86–91. 42 indexed citations
11.
Kelly, Deanna L., Heidi J. Wehring, Jared Linthicum, et al.. (2008). Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone. Schizophrenia Research. 107(2-3). 134–138. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026